It’s always my steadfast mission to know which surgical methods will make patients feel more at ease and reassured that their health is in the best hands possible. This is certainly the case when a biopsy or lumpectomy is required.
Why One Young Mother Choose A Double Mastectomy After DCIS Diagnosis
One of our beloved patients was recently featured in the Citizen Tribune about her experience with DCIS breast cancer. The information in this blog post was gathered from that article:
Whitney Danehy McGowen was 33 years old when she went for a regular checkup with her obstetrician in the late fall of 2017. She mentioned a slight change in her left breast and her obstetrician, while not overly concerned, suggested it was a good reason to get a baseline mammogram since she had a family history of breast cancer.
Read more on Why One Young Mother Choose A Double Mastectomy After DCIS Diagnosis …
BRCA gene, breast cancer genetic testing, DCIS, Knoxville breast cancer surgeonFirst Immunotherapy Regimen for Triple-Negative Breast Cancer Approved By FDA
The U.S. Food and Drug Administration has recently granted its first approval to an immunotherapy regimen for Triple Negative Breast Cancer, which is significant because Triple Negative Breast Cancer tumors are generally high-grade, aggressive, and typically more likely to spread and recur.
Read more on First Immunotherapy Regimen for Triple-Negative Breast Cancer Approved By FDA…
Immunotherapy for breast cancer, Triple Negative breast cancer treatmentClearing Up Confusion Over Recent Mammography Guidelines
Hands down and without a doubt, mammograms are the best way to detect breast cancer early. Mammograms save lives, and so it’s crucial for every woman to know when she should be having them, and how frequently.
Read more on Clearing Up Confusion Over Recent Mammography Guidelines…
breast cancer treatment Knoxville, Mammogram guidelinesLow Dose Tamoxifen Reduces Risk Of Recurrence For Some Breast Cancers
For women diagnosed with hormone-receptor-positive DCIS, a new study has determined that low dose Tamoxifen after surgery reduced the risk of the disease coming back. Low dose tamoxifen also reduced the risk of developing a new invasive breast cancer.
Read more on Low Dose Tamoxifen Reduces Risk Of Recurrence For Some Breast Cancers…
ADH, ALH breast cancers, DCIS, LCIS, reduce breast cancer recurrenceKnowledge Is Power When It Comes To Genetic Testing: WBIR Segment
Our Director of Clinical Genetics Service, Imelda G. Margulies, FNP (who is also my beloved wife of 22 years), was featured on WBIR’s Buddy Check 10 series recently. She explained what genetic testing is, how it’s done, and why it’s important.
Read more on Knowledge Is Power When It Comes To Genetic Testing: WBIR Segment…
BRCA gene, Genetic testing and breast cancerCan Some Types Of Breast Cancer Be Cured Without Surgery?
Many patients assume that surgery is the first step towards treatment, and this is true in that doctors do typically recommend surgery to remove a tumor for both early-stage invasive breast cancer and DCIS.
Read more on Can Some Types Of Breast Cancer Be Cured Without Surgery?…
her2-positive breast cancer, Triple Negative Breast CancerNew Research Links BRCA2 Breast Cancer Gene With Pancreatic Cancer Risk
According to the American Cancer Society, pancreatic cancer is currently the third leading cause of cancer-related deaths in the U.S., and rates are rising faster than any other cancer in the country. Researchers predict it will become the second deadliest cancer in the U.S. by 2030, second only to lung cancer.
Read more on New Research Links BRCA2 Breast Cancer Gene With Pancreatic Cancer Risk…
BRCA gene, pancreatic cancer treatment, PARP-IMore Hope For PARP Inhibitors In Treating Breast Cancer
We hosted a dinner on PARP Inhibitors recently. PARP Inhibitors are a class of medications that may have benefits in Triple Negative and other Breast Cancers in women with a BRCA mutation. Homologous Recombination Deficiencies are associated with several cancers, including breast cancer, and can be identified in breast cancer tissue itself. Tumors with a homologous recombination deficiency (including BRCA mutations) are described as HRD-positive.
Read more on More Hope For PARP Inhibitors In Treating Breast Cancer…
BRCA gene, HRD, PARP-I, Triple Negative Breast CancerMy Latest Certification Will Help Me Deliver The Best Possible Cosmetic Results
I am proud to have earned a Certification in Oncoplastic Surgery Education from the School of Oncoplastic Surgery. This is significant for my patients because oncoplastic surgery is considered the most advanced form of breast cancer surgery. It combines surgery to remove the breast cancer with plastic and reconstructive techniques to reshape the breasts for the best possible cosmetic results.
Read more on My Latest Certification Will Help Me Deliver The Best Possible Cosmetic Results…
Breast Reconstruction, Oncoplastic Breast Surgeon